- Home
- IQV vs CAH Comparison
IQV vs CAH Comparison
Compare IQV & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IQV
- CAH
- Stock Information
- Founded
- IQV 1982
- CAH 1979
- Country
- IQV United States
- CAH United States
- Employees
- IQV N/A
- CAH N/A
- Industry
- IQV Biotechnology: Commercial Physical & Biological Resarch
- CAH Other Pharmaceuticals
- Sector
- IQV Health Care
- CAH Health Care
- Exchange
- IQV Nasdaq
- CAH Nasdaq
- Market Cap
- IQV 36.4B
- CAH 36.4B
- IPO Year
- IQV 2013
- CAH N/A
- Fundamental
- Price
- IQV $208.58
- CAH $200.00
- Analyst Decision
- IQV Buy
- CAH Buy
- Analyst Count
- IQV 18
- CAH 11
- Target Price
- IQV $237.89
- CAH $196.36
- AVG Volume (30 Days)
- IQV 1.8M
- CAH 2.4M
- Earning Date
- IQV 10-28-2025
- CAH 10-30-2025
- Dividend Yield
- IQV N/A
- CAH 1.03%
- EPS Growth
- IQV N/A
- CAH 27.25
- EPS
- IQV 7.30
- CAH 6.63
- Revenue
- IQV $15,904,000,000.00
- CAH $234,310,000,000.00
- Revenue This Year
- IQV $6.14
- CAH $15.26
- Revenue Next Year
- IQV $5.28
- CAH $8.34
- P/E Ratio
- IQV $28.87
- CAH $29.87
- Revenue Growth
- IQV 3.85
- CAH 4.39
- 52 Week Low
- IQV $134.65
- CAH $113.65
- 52 Week High
- IQV $225.91
- CAH $200.14
- Technical
- Relative Strength Index (RSI)
- IQV 49.84
- CAH 87.54
- Support Level
- IQV $207.01
- CAH $188.15
- Resistance Level
- IQV $212.68
- CAH $200.14
- Average True Range (ATR)
- IQV 5.82
- CAH 4.66
- MACD
- IQV -1.71
- CAH 3.52
- Stochastic Oscillator
- IQV 10.15
- CAH 96.52
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
About CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.